Side-by-side comparison of AI visibility scores, market position, and capabilities
New York specialty ingredients (NYSE: IFF) at $11.48B 2024 net sales, EBITDA +16%; flavors/fragrances + N&B health/biosciences ($26B 2021 acquisition), 2025 guidance 1-4% growth competing with Givaudan and dsm-firmenich.
International Flavors & Fragrances Inc. (IFF) is a New York City, New York-based global specialty ingredients company — publicly traded on the New York Stock Exchange (NYSE: IFF) as an S&P 500 Materials component — creating and manufacturing flavors, fragrances, enzymes, probiotics, food ingredients, cosmetic actives, and pharmaceutical excipients for consumer goods companies, food manufacturers, beverage companies, and pharmaceutical firms through approximately 20,000 employees in 110 countries. In fiscal year 2024, IFF reported net sales of $11.48 billion and adjusted operating EBITDA growth of 16% to $2.21 billion, demonstrating improved profitability following the challenging integration of the DuPont Nutrition & Biosciences business (acquired 2021 for ~$26 billion in the largest transaction in IFF's history). For 2025, IFF guided 1-4% comparable currency-neutral sales growth, with continued margin improvement as the integration synergies are realized. CEO Jon Erik Fyrwald leads the company through its integration and portfolio optimization phase. IFF operates across four segments: Nourish (flavors, functional ingredients, proteins, food and beverage innovation), Scent (fine fragrances, consumer fragrances, cosmetic actives), Health & Biosciences (enzymes, microbiome, probiotics, animal nutrition), and Pharma Solutions (pharmaceutical excipients and delivery systems) — serving every major category of consumer products from food and beverages to personal care, household products, and medicine.
Bellevue WA premium commercial trucks (NASDAQ: PCAR) at $33.66B 2024 revenue, $4.16B earnings, 86th consecutive profitable year; Kenworth/Peterbilt 30.7% Class 8 market share, hydrogen FCEV deliveries 2025 competing with Daimler Freightliner.
PACCAR Inc. is a Bellevue, Washington-based premium commercial truck manufacturer — publicly traded on NASDAQ (NASDAQ: PCAR) as an S&P 500 Industrials component — designing and manufacturing heavy and medium-duty trucks under the Kenworth (North America), Peterbilt (North America), and DAF (Europe) brands through manufacturing facilities in the US, Netherlands, UK, Mexico, Brazil, and Australia, reporting $33.66 billion in 2024 revenue (second-best in company history), $4.16 billion in earnings, and its 86th consecutive year of net income. Founded in 1905 by William Pigott as a steel foundry and evolving through Seattle Car Manufacturing, Pacific Car and Foundry, and ultimately PACCAR, the company has built one of the most respected brands in long-haul trucking. In 2024, Kenworth and Peterbilt combined for 30.7% US and Canadian Class 8 heavy truck retail sales market share, with 185,300 vehicles delivered globally. PACCAR Parts (aftermarket parts distribution) set records with $6.67 billion in revenue and $1.71 billion in pretax income, demonstrating the high-margin recurring revenue stream from servicing the installed base of 1+ million PACCAR trucks. For 2025, PACCAR planned $700-800 million in capital projects and $460-500 million in R&D investment, targeting electric vehicle commercial production, hydrogen fuel cell truck delivery, and autonomous driving technology development. The Amplify Cell Technologies joint venture (with Daimler Truck and Accelera by Cummins, $2-3 billion investment) localizes battery cell manufacturing for electric Class 8 trucks in the US.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.